Three-Dimensional-Printed Gelatin Methacryloyl Scaffold Loaded with Extracellular Vesicles Derived from H2S Preconditioned Mesenchymal Stromal Cells Promotes Neuronal Regeneration in Rats with Spinal Cord Injury
Source abstract
Abstract
Background: spinal cord injury (SCI) causes irreversible motor and sensory deficits with limited effective treatments. Mesenchymal stromal cells (MSCs) exert therapeutic effects largely through extracellular vesicles (EVs). Preconditioning MSCs with a hydrogen sulfide (H 2 S) donor enhance the therapeutic potential of EVs. Objective: this study is aimed to develop a 3D-printed gelatin methacryloyl (GelMA) scaffold loaded with H 2 S-preconditioned MSC-derived EVs (H 2 S-EVs) to promote motor function recovery in SCI. Methods: H 2 S-EVs were isolated from NaHS (an H 2 S donor)-preconditioned MSCs and incorporated into a 3D-printed GelMA scaffold (3D/GelMA/EVs). Scaffold mechanical properties and H 2 S-EVs. The scaffold’s therapeutic efficacy was evaluated in a rat SCI model. Results: MiRNA microarray revealed miR-7a-5p as the most upregulated miRNA in H 2 S-EVs. The 3D/GelMA/EVs scaffold exhibited an appropriate elastic modulus and porous structure, enabling sustained local EVs release. In vivo, the scaffold significantly improved motor function recovery in SCI rats. Conclusion: these results indicated that H 2 S-EVs provided an important therapeutic tool against SCI by miR-7a-5p and 3D/GelMA/EVs scaffolds were ideal biomaterials for the intervention of SCI.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · Mesenchymal stem cell research · MXene and MAX Phase Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine
Shandong University
Department of Neurology the Second Hospital of Shandong University
Department of Medical Psychology and Ethics, School of Basic Medicine Sciences, Cheeloo College of Medicine
Funding
National Natural Science Foundation of China · Natural Science Foundation of Shandong Province
References (49)
Show source-provided references
1. 10.1186/s40779-023-00461-z10.1186/s40779-023-00461-z ↗
2. 10.1002/ptr.817910.1002/ptr.8179 ↗
3. 10.1152/physrev.00017.201710.1152/physrev.00017.2017 ↗
4. 10.1007/s10787-024-01478-z10.1007/s10787-024-01478-z ↗
5. 10.1016/j.bioactmat.2023.06.01310.1016/j.bioactmat.2023.06.013 ↗
6. 10.1016/j.prp.2024.15535410.1016/j.prp.2024.155354 ↗
7. 10.3390/ijms22241367210.3390/ijms222413672 ↗
8. 10.1186/s13287-021-02153-810.1186/s13287-021-02153-8 ↗
9. 10.1111/jcmm.1349210.1111/jcmm.13492 ↗
10. 10.1038/s41586-018-0089-z10.1038/s41586-018-0089-z ↗
11. 10.1186/s12974-020-1726-710.1186/s12974-020-1726-7 ↗
12. 10.1016/j.ajpath.2024.07.02210.1016/j.ajpath.2024.07.022 ↗
13. 10.1007/s10557-019-06927-410.1007/s10557-019-06927-4 ↗
14. 10.1016/j.niox.2020.07.00210.1016/j.niox.2020.07.002 ↗
15. Jafar Sameri M. · Rep. Biochem Mol. Biol. · 2023 · 11 · 644
16. 10.1016/j.bbrc.2022.09.11110.1016/j.bbrc.2022.09.111 ↗
17. 10.1016/j.bioactmat.2023.08.00610.1016/j.bioactmat.2023.08.006 ↗
18. 10.1016/j.jconrel.2020.08.03710.1016/j.jconrel.2020.08.037 ↗
19. 10.34133/cbsystems.004310.34133/cbsystems.0043 ↗
20. 10.34133/cbsystems.001810.34133/cbsystems.0018 ↗
21. 10.1021/acs.chemrev.9b0080810.1021/acs.chemrev.9b00808 ↗
22. 10.22203/eCM.v045a1110.22203/eCM.v045a11 ↗
23. 10.1002/adhm.20210058110.1002/adhm.202100581 ↗
24. 10.3389/fbioe.2024.134516310.3389/fbioe.2024.1345163 ↗
25. 10.1002/advs.20220452810.1002/advs.202204528 ↗
26. 10.4103/1673-5374.33687110.4103/1673-5374.336871 ↗
27. 10.1080/20013078.2018.153575010.1080/20013078.2018.1535750 ↗
28. 10.1016/0002-9394(88)90196-110.1016/0002-9394(88)90196-1 ↗
29. 10.1016/j.biomaterials.2010.03.06410.1016/j.biomaterials.2010.03.064 ↗
30. 10.1021/acsami.8b0529310.1021/acsami.8b05293 ↗
31. 10.2217/nnm-2021-002510.2217/nnm-2021-0025 ↗
32. 10.2147/IJN.S44896210.2147/IJN.S448962 ↗
33. 10.1016/j.actbio.2021.03.01810.1016/j.actbio.2021.03.018 ↗
34. 10.1016/j.actbio.2023.07.02010.1016/j.actbio.2023.07.020 ↗
35. 10.1186/s13287-024-03655-x10.1186/s13287-024-03655-x ↗
36. 10.1016/j.actbio.2019.12.02010.1016/j.actbio.2019.12.020 ↗
37. 10.1182/blood-2014-05-57611610.1182/blood-2014-05-576116 ↗
38. 10.1186/s12929-015-0135-110.1186/s12929-015-0135-1 ↗
39. 10.1016/0014-2999(89)90382-810.1016/0014-2999(89)90382-8 ↗
40. 10.1186/s13287-021-02282-010.1186/s13287-021-02282-0 ↗
41. 10.1038/s41419-022-04934-210.1038/s41419-022-04934-2 ↗
42. 10.1126/scisignal.aat428510.1126/scisignal.aat4285 ↗
43. 10.1016/j.expneurol.2024.11474810.1016/j.expneurol.2024.114748 ↗
44. 10.1016/j.phrs.2024.10718910.1016/j.phrs.2024.107189 ↗
45. 10.1523/JNEUROSCI.18-09-03251.199810.1523/JNEUROSCI.18-09-03251.1998 ↗
46. 10.4103/1673-5374.35020910.4103/1673-5374.350209 ↗
47. 10.1111/j.1742-4658.2008.06767.x10.1111/j.1742-4658.2008.06767.x ↗
48. 10.1038/s41591-018-0296-z10.1038/s41591-018-0296-z ↗
49. 10.1016/j.actbio.2022.11.04110.1016/j.actbio.2022.11.041 ↗